Search results

11 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
By forming clots in tumors, immune cells aid lung cancer's spread
Researchers led by UNC Lineberger's Chad Pecot, MD, report in the journal Nature Communications that for a particular subset of lung cancer tumors, there is a high prevalence of immune cells called inflammatory monocytes. These cells, which normally help to build clotting scaffolds to promote wound healing, also make it possible for tumor cells to migrate and spread to other parts of the body.
Located in News
Carrie Lee
Carrie Lee, MD, MPH , is a UNC Lineberger Comprehensive Cancer Center member and Assistant Professor of Medicine in the Division of Hematology and Oncology at UNC-Chapel Hill. Lee is involved with Clinical Research and the Thoracic Oncology Program.
Located in People / Profiles
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
UNC analysis shows advantage for picture-based cigarette pack warnings over text warnings
A University of North Carolina at Chapel Hill analysis published today in the journal Tobacco Control synthesized the results of 37 different experiments comparing picture-based and text warnings, finding that picture-based warnings were more effective than text warnings on 20 of 25 different outcome measures.
Located in News
Located in Newsroom / UNC Lineberger in the News
UNC pulmonology fellow wins grant for lung cancer research
Adam Belanger, MD, a second-year pulmonology fellow in pulmonary diseases and critical care medicine at the UNC School of Medicine, was one of four North Carolina researchers to win a research grant from the Lung Cancer Initiative of North Carolina’s Research Fellows Program.
Located in News
Bobby Kadis: Living life to the fullest
These days Bobby Kadis is living life to the fullest. After being diagnosed with Stage 4 lung cancer, he enrolled in a UNC Lineberger clinical trial using a combination of targeted drug therapies. Now the avid potter, mountain climber and yoga enthusiast celebrates being cancer-free.
Located in News